What are the recommended pharmacologic treatments for insomnia in a 34‑year‑old woman and what assessment questions should be asked regarding her poor sleep?

Recommended Medications for Sleep in a 34-Year-Old Woman

For a 34-year-old woman with insomnia, eszopiclone (2-3 mg) or zolpidem (10 mg) are the most evidence-based first-line pharmacologic options if she has both sleep onset and maintenance problems, while zaleplon (10 mg) is preferred if she only has difficulty falling asleep. 1

Medication Selection Algorithm

For Sleep Onset Insomnia Only:

• Zaleplon 10 mg (short half-life, minimal next-day effects) 1
• Alternative: Triazolam 0.25 mg 1
• Alternative: Ramelteon 8 mg (if concerned about abuse potential) 1

For Sleep Maintenance Insomnia Only:

• Doxepin 3-6 mg (low-dose tricyclic) 1
• Alternative: Suvorexant 10-20 mg (orexin receptor antagonist) 1

For Both Sleep Onset AND Maintenance:

• Eszopiclone 2-3 mg 1
• Zolpidem 10 mg 1
• Temazepam 15 mg 1

Critical Dosing Consideration for Women

Important caveat: The FDA specifically advises dose reduction in women for many hypnotics due to slower metabolism. For zolpidem in particular, women should receive lower doses than the 10 mg studied, as they are at higher risk for driving impairment and cognitive changes 2.

Medications to AVOID

Do NOT use the following despite their common use in practice:

• Trazodone - insufficient evidence, harms may outweigh benefits 1
• Diphenhydramine (Benadryl) - not recommended 1
• Melatonin (OTC formulations) - insufficient evidence 1
• Tiagabine - harms outweigh benefits 1

Evidence Quality and Limitations

The American Academy of Sleep Medicine guidelines 1 provide WEAK recommendations for all pharmacologic agents, meaning benefits outweigh harms but with low to moderate quality evidence. Effect sizes are small to moderate 2, 1. All recommendations are based on short-term trials (≥4 weeks), and long-term efficacy beyond 3 months is not established 2.

Safety Concerns

Observational studies suggest hypnotic use is associated with increased risk for:

• Dementia
• Fractures
• Major injury
• Cognitive and behavioral changes
• Driving impairment 2

These risks increase with age and are particularly relevant for benzodiazepines and benzodiazepine receptor agonists.

---

Essential Assessment Questions for Poor Sleep in a 34-Year-Old Woman

Sleep Pattern Characterization

Determine the specific insomnia phenotype:

• Sleep onset: How long does it take you to fall asleep after getting into bed? (Normal <30 minutes)
• Sleep maintenance: Do you wake up during the night? How many times? Can you fall back asleep?
• Early morning awakening: Do you wake up earlier than desired and cannot return to sleep?
• Total sleep time: How many hours of actual sleep do you get per night?
• Sleep efficiency: What percentage of time in bed are you actually sleeping?

Chronicity and Severity

• Duration: How long has this been occurring? (Insomnia disorder requires ≥3 months, ≥3 nights/week) 2
• Frequency: How many nights per week?
• Daytime consequences: Does poor sleep cause clinically significant distress or impair your work, social activities, or daily functioning? 2

Sleep Opportunity and Environment

• Adequate opportunity: Do you have sufficient time allocated for sleep (7-9 hours in bed)?
• Sleep hygiene: What is your bedtime routine? Screen time before bed? Caffeine/alcohol use? Exercise timing?
• Bedroom environment: Temperature, noise, light exposure, bed partner disturbances?

Medical and Psychiatric Comorbidities

Screen for conditions that cause or coexist with insomnia:

Psychiatric:

• Depression: Low mood, anhedonia, suicidal ideation?
• Anxiety disorders: Worry, panic attacks, PTSD symptoms?
• Substance use: Alcohol, stimulants, cannabis?

Medical:

• Pain syndromes: Chronic pain keeping you awake?
• Gastroesophageal reflux: Nighttime heartburn?
• Respiratory: Asthma, COPD symptoms at night?
• Endocrine: Thyroid symptoms, hot flashes, night sweats?
• Urinary: Nocturia frequency?

Medications:

• Current medications: Stimulants, corticosteroids, beta-blockers, SSRIs, decongestants?

Other Sleep Disorders (Differential Diagnosis)

Rule out conditions requiring polysomnography:

• Sleep apnea: Snoring, witnessed apneas, gasping, excessive daytime sleepiness, obesity, large neck circumference?
• Restless legs syndrome: Uncomfortable sensations in legs with urge to move, worse at rest, relieved by movement?
• Periodic limb movement disorder: Bed partner reports leg jerking during sleep?
• Circadian rhythm disorders: Shift work? Jet lag? Delayed sleep phase (natural night owl)?
• Narcolepsy: Excessive daytime sleepiness, cataplexy, sleep paralysis?

Women-Specific Considerations

For a 34-year-old woman, specifically ask:

• Menstrual cycle: Does sleep worsen premenstrually or during menses?
• Pregnancy: Current or recent pregnancy? Postpartum period?
• Hormonal contraception: Recent changes in birth control?
• Perimenopausal symptoms: (Less likely at 34, but possible) - hot flashes, night sweats, irregular periods?

Red Flags Requiring Further Workup

• Loud snoring with witnessed apneas → Sleep study for OSA
• Irresistible urge to move legs at night → Consider RLS/PLMD, check ferritin
• Excessive daytime sleepiness despite adequate sleep opportunity → Sleep study for narcolepsy or OSA
• Treatment-resistant insomnia → Polysomnography 2

Baseline Assessment Tools

Use validated questionnaires:

• Insomnia Severity Index (ISI) - measures distress and dysfunction
• Pittsburgh Sleep Quality Index - comprehensive sleep quality assessment
• Sleep diary - 1-2 weeks of patient-reported sleep patterns 2

Actigraphy is NOT recommended for routine insomnia evaluation but may help with differential diagnosis 3.